What You Should Know: FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, and Eko Health, Inc. (“Eko”), a leading innovator in digital health technology for heart and lung disease detection, today announced the launch of the FIGS | Eko CORE 500TM Digital Stethoscope.The collaboration unites two companies that have reinvented two healthcare professionals’ mainstays — scrubs and stethoscopes — through new technology, modern design, and authentic
Read More
Eko Devices
Eko Health Launches AI-Enhanced Digital Stethoscope
What You Should Know: Eko Health today announced the launch of its next-generation AI-enhanced digital stethoscope, CORE 500™. Engineered to enhance diagnostic accuracy and early disease detection, the CORE 500™ combines artificial intelligence (AI) software, high-fidelity audio experience, full-color display, and 3-lead electrocardiogram (ECG) to deliver an essential patient assessment tool for healthcare professionals (HCPs). CORE 500 Features The CORE
Read More
Eko Launches Cardiac Disease Detection Platform, SENSORA
What You Should Know: - Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease launches the SENSORA™ Cardiac Disease Detection Platform. - SENSORA™ currently features AI that objectively identifies structural murmurs, a sign of valvular heart disease, and Care Pathway Analytics software that provides downstream visibility and metrics of the patient journey through the healthcare system. Eko SENSORA Cardiac Disease Detection
Read More
FDA Clears Eko’s Heart Disease Detection AI for Adults and Pediatrics
What You Should Know: - Today, Eko, a digital health company advancing heart and lung disease detection, has announced the FDA has issued clearance for its Eko Murmur Analysis Software (EMAS), the first and only machine learning algorithm to screen for valvular heart disease (VHD). - The next generation of Eko’s murmur detection capabilities grants Eko the first and only smart stethoscope on the market that can identify and
Read More
Eko Unveils Newly Designed Heart Disease Detection App
What You Should Know: - Eko, a digital health company advancing heart and lung disease detection, today announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease. Heart disease is the leading cause of death in the U.S., and there has not been an efficient and affordable solution to screen for heart disease at the physical exam until now. - Eko has transformed the traditional stethoscope into an
Read More
Eko Launches Next Generation DUO ECG + Digital Stethoscope for Frontline Clinicians
What You Should Know: - Eko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management. - DUO is a pocket-sized cardiac examination system for clinicians used to detect early signs of heart disease and facilitate timely care for patients in and out of the clinic.
Read More
Eko’s AI Algorithm Validated as a Clinical Tool for Detecting Heart Murmurs
What You Should Know: - Eko, a cardiopulmonary digital health company, today announced the peer-reviewed publication of a clinical study that found that the Eko artificial intelligence (AI) algorithm for detecting heart murmurs is accurate and reliable, with comparable performance to that of an expert cardiologist. - The findings suggest utility of the FDA-cleared Eko AI algorithm as a front line clinical tool to aid clinicians in screening for cardiac murmurs
Read More
Eko Lands $65M to Expand AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
What You Should Know: - Cardiopulmonary digital health company Eko raises $65M in Series C funding to close the gap between virtual and in-person heart and lung care. - The latest round of funding will enable Eko to expand in-clinic use of its platform of telehealth and AI algorithms for disease screening and to launch a monitoring program for cardiopulmonary patients at home. Eko, a cardiopulmonary digital health company, today announced $65 million in Series C funding led by
Read More
3M and Eko Launches 3M Littmann® CORE Digital Stethoscope for Clinicians
What You Should Know: - 3M and Eko team up to launch 3M Littmann® CORE Digital Stethoscope to deliver a game-changing tool for clinicians as they assess, diagnose, and monitor their patients. - The new 3M Littmann CORE Digital Stethoscope offers clinicians access to both analog and digital auscultation options and connects to Eko’s software and AI algorithms* to help clinicians better interpret sounds and detect heart murmurs. 3M™ Littmann® Stethoscopes and Eko, today announced the
Read More
FDA Grants Eko Emergency Use Authorization for Low Ejection Fraction AI
What You Should Know: - The FDA granted Emergency Use Authorization to Eko for an ECG-based algorithm that screens for low ejection fraction, as part of an assessment of cardiac complications and co-morbidities associated with COVID-19. - This ECG-based deep learning algorithm, developed on a large clinical dataset in collaboration with the Mayo Clinic, can help efficiently identify signs of possible heart failure in patients. Eko, a digital health company building
Read More